Systemic treatment of penile cancer: New concepts? New achievements?

Aktuelle Urol. 2023 Aug;54(4):304-312. doi: 10.1055/a-2104-1418. Epub 2023 Aug 4.ABSTRACTSystemic chemotherapy has been in use for metastatic penile carcinoma for years, but its success is limited. Its significance is largely associated with its role in multimodal treatment for lymphatic metastasis in the context of radical lymph node surgery. In cases of limited lymph node involvement, the combination of surgical treatment plus cisplatin- and taxane-based triple combinations may be curative. Advances in the understanding of molecular changes in penile cancer and the search for potential therapy targets have led to numerous studies. Although there is evidence of efficacy of immunotherapeutics, no significant therapeutic improvements have been seen in the clinical routine.PMID:37541237 | DOI:10.1055/a-2104-1418
Source: Aktuelle Urologie - Category: Urology & Nephrology Authors: Source Type: research